Patents by Inventor Jaime A. Eberle-Singh

Jaime A. Eberle-Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12023335
    Abstract: A method for treating pancreatic cancer in a subject in need thereof comprising, administering to the subject an effective amount of a tubulin polymerization inhibitor compound is described herein. More particularly, a method for treating pancreatic ductal adenocarcinoma in a subject in need thereof comprising, administering to the subject an effective amount of a substituted reverse pyrimidine tubulin polymerization inhibitor compound alone or in combination with other chemo-therapeutic agents is described herein.
    Type: Grant
    Filed: August 17, 2019
    Date of Patent: July 2, 2024
    Assignee: PTC THERAPEUTICS, INC.
    Inventors: Marla L. Weetall, Liangxian Cao, Thomas W. Davis, Melissa L. Dumble, Jaime A. Eberle-Singh, Kenneth P. Olive
  • Publication number: 20210236492
    Abstract: A method for treating pancreatic cancer in a subject in need thereof comprising, administering to the subject an effective amount of a tubulin polymerization inhibitor compound is described herein. More particularly, a method for treating pancreatic ductal adenocarcinoma in a subject in need thereof comprising, administering to the subject an effective amount of a substituted reverse pyrimidine tubulin polymerization inhibitor compound alone or in combination with other chemo-therapeutic agents is described herein.
    Type: Application
    Filed: August 17, 2019
    Publication date: August 5, 2021
    Inventors: Marla L. Weetall, Liangxian Cao, Thomas W. Davis, Melissa L. Dumble, Jaime A. Eberle-Singh, Kenneth P. Olive